Since we find that the PD-1 tumor-infiltrating NK cells are expressed primarily in the CXCR6+ NK cell population, this may open up new possiblities to investigate the function of NK cells in the setting of PD-1/PD-L1 therapy. Here, CXCR6 is linked to neoplasm.